Effect of Pulsatile Left Ventricular Assist System Implantation on Doppler Measurements of Renal Hemodynamics in Patients With Advanced Heart Failure

Artificial Organs

Volumn 36, Issue 4, 2012, Pages 353-358

  Iwashima, Yoshio ^a   Yanase, Masanobu ^a   Horio, Takeshi ^a   Seguchi, Osamu ^a   Murata, Yoshihiro ^a   Fujita, Tomoyuki ^a   Toda, Kouichi ^a   Kawano, Yuhei ^a   Nakatani, Takeshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Heart assist system; Heart failure; Kidney; Renal hemodynamics

Indexed keywords

ARTIFICIAL HEART; BLOOD; CARDIOLOGY; FIBER OPTIC SENSORS; HEMODYNAMICS; LEFT VENTRICULAR ASSIST DEVICES;

GLOMERULAR FILTRATION RATE; HEART ASSIST SYSTEM; HEART FAILURE; KIDNEY; LEFT VENTRICULAR ASSIST SYSTEMS; MEASUREMENTS OF; PEAK SYSTOLIC VELOCITIES; PULSATILES; RENAL FUNCTIONS; RENAL HEMODYNAMICS;

HEART;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DISEASE SEVERITY; DOPPLER FLOWMETRY; END DIASTOLIC VELOCITY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HEART BEAT; HEART FAILURE; HEART PERFUSION; HEART RATE; HEART TRANSPLANTATION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY VASCULAR RESISTANCE; LEFT VENTRICULAR ASSIST SYSTEM; MALE; PEAK SYSTOLIC VELOCITY; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; RESISTIVE INDEX;

EID: 84857562597     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01351.x     Document Type: Article

References (31)

1. Hunt SA, Abraham WT, Chin MH, etal. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-e90.
2. Kirklin JK, Naftel DC. Mechanical circulatory support: registering a therapy in evolution. Circ Heart Fail 2008;1:200-5.
3. Rose EA, Gelijns AC, Moskowitz AJ, etal. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
4. Nakatani T. Heart transplantation. Circ J 2009;73:A55-A60.
5. Mehra MR, Kobashigawa J, Starling R, etal. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006;25:1024-42.
6. Frazier OH, Rose EA, Oz MC, etal. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122:1186-95.
7. Farrar DJ, Hill JD. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant 1994;13:1125-32.
8. Krumme B. Renal Doppler sonography-update in clinical nephrology. Nephron Clin Pract 2006;103:c24-8.
9. Tublin ME, Bude RO, Platt JF. Review. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol 2003;180:885-92.
10. Takano H, Nakatani T. Ventricular assist systems: experience in Japan with Toyobo pump and Zeon pump. Ann Thorac Surg 1996;61:317-22.
11. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
12. Imai E, Horio M, Nitta K, etal. Modification of the Modification of Diet in Renal Disease (MDRD) study equation for Japan. Am J Kidney Dis 2007;50:927-37.
13. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 2006;47:195-202.
14. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Pulmonary venous flow and risk of cardiovascular disease in essential hypertension. J Hypertens 2008;26:798-805.
15. Lang RM, Bierig M, Devereux RB, etal. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
16. Radermacher J, Chavan A, Bleck J, etal. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344:410-7.
17. Radermacher J, Mengel M, Ellis S, etal. The renal arterial resistance index and renal allograft survival. N Engl J Med 2003;349:115-24.
18. Murphy ME, Tublin ME. Understanding the Doppler RI: impact of renal arterial distensibility on the RI in a hydronephrotic ex vivo rabbit kidney model. J Ultrasound Med 2000;19:303-14.
19. Schwenger V, Keller T, Hofmann N, etal. Color Doppler indices of renal allografts depend on vascular stiffness of the transplant recipients. Am J Transplant 2006;6:2721-4.
20. Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation 2010;121:2592-600.
21. Mullens W, Abrahams Z, Francis GS, etal. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589-96.
22. Brennan JM, Blair JE, Goonewardena S, etal. Reappraisal of the use of inferior vena cava for estimating right atrial pressure. J Am Soc Echocardiogr 2007;20:857-61.
23. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990;66:493-6.
24. Maslovitz S, Jaffa A, Eytan O, etal. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Obstet Gynecol 2004;104:321-6.
25. James KB, McCarthy PM, Thomas JD, etal. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995;92:II191-5.
26. Nakano T, Tominaga R, Morita S, etal. Impacts of pulsatile systemic circulation on endothelium-derived nitric oxide release in anesthetized dogs. Ann Thorac Surg 2001;72:156-62.
27. Miller LW, Pagani FD, Russell SD, etal. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96.
28. Slaughter MS, Rogers JG, Milano CA, etal. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
29. Letsou GV, Myers TJ, Gregoric ID, etal. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg 2003;76:1167-70.
30. Sandner SE, Zimpfer D, Zrunek P, etal. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant 2008;27:469-73.
31. Sandner SE, Zimpfer D, Zrunek P, etal. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009;87:1072-8.